Carpenter Technology Acquires Fine Gas Powder Company For Metal Injection Molding

Carpenter Technology Corporation, today announced its Carpenter Powdered Products, Inc. subsidiary, has acquired the assets and business of UltraFine Powder Technology Inc., a private company in Woonsocket, RI. UltraFine is a leader in the manufacture and sale of fine gas atomized powders for the metal injection molding (MIM) industry and other specialty markets.

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from those projected, anticipated or implied. The most significant of these uncertainties are described in Carpenter's filings with the Securities and Exchange Commission including its annual report on Form 10-K for the year ended June 30, 2007, its subsequent Form 10-Q, and the exhibits attached to those filings.

They include but are not limited to: 1) the cyclical nature of the specialty materials business and certain end-use markets, including aerospace, industrial, automotive, consumer, medical, and energy including power generation, or other influences on Carpenter's business such as new competitors, the consolidation of customers and suppliers or the transfer of manufacturing capacity from the United States to foreign countries; 2) the ability of Carpenter to achieve cost savings, productivity improvements or process changes; 3) the ability to recoup increases in the cost of energy and raw materials or other factors; 4) domestic and foreign excess manufacturing capacity for certain metals; 5) fluctuations in currency exchange rates; 6) the degree of success of government trade actions; 7) the valuation of the assets and liabilities in Carpenter's pension trusts and the accounting for pension plans; 8) possible labor disputes or work stoppages; 9) the potential that our customers may substitute alternate materials or adopt different manufacturing practices that replace or limit the suitability of our products; 10) the ability to successfully acquire and integrate acquisitions; 11) the ability of Carpenter to implement and manage material capital expansion projects in a timely and efficient manner; and 12) the pending sale of its ceramics operations.

Any of these factors could have an adverse and/or fluctuating effect on Carpenter's results of operations. The forward-looking statements in this document are intended to be subject to the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Carpenter undertakes no obligation to update or revise any forward-looking statements.

Posted March 30th,2008

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Carpenter Technology Corporation. (2019, February 10). Carpenter Technology Acquires Fine Gas Powder Company For Metal Injection Molding. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=11729.

  • MLA

    Carpenter Technology Corporation. "Carpenter Technology Acquires Fine Gas Powder Company For Metal Injection Molding". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=11729>.

  • Chicago

    Carpenter Technology Corporation. "Carpenter Technology Acquires Fine Gas Powder Company For Metal Injection Molding". AZoM. https://www.azom.com/news.aspx?newsID=11729. (accessed November 21, 2024).

  • Harvard

    Carpenter Technology Corporation. 2019. Carpenter Technology Acquires Fine Gas Powder Company For Metal Injection Molding. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=11729.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.